Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CHEK | US
1.00
0.74%
Healthcare
Diagnostics & Research
31/03/2024
06/04/2026
136.00
135.00
136.00
134.00
Check-Cap Ltd. a clinical stage medical diagnostics company engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap an X-ray scanning capsule for detection of suspected polyps; C-Scan Track a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software a client/server-based application that enables procedure data download from the C-Scan Track data analysis and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya Israel.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
17.3%1 month
17.9%3 months
28219.3%6 months
29624.3%-
-
0.37
-
-
0.74
-
-
-17.65M
795.49M
795.49M
-
-
-
-
-54.06
0.73
0.23
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
5.00
Range1M
13.00
Range3M
169.55
Rel. volume
0.80
Price X volume
105.16M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CASTLE BIOSCIENCES INC | CSTL | Diagnostics & Research | 24.73 | 685.93M | -0.44% | n/a | 5.94% |
| Atossa Genetics Inc | ATOS | Diagnostics & Research | 5.15 | 647.65M | -4.01% | n/a | 0.00% |
| Fulgent Genetics Inc | FLGT | Diagnostics & Research | 16.42 | 497.47M | -2.38% | n/a | 1.18% |
| Personalis Inc | PSNL | Diagnostics & Research | 6.58 | 433.85M | 0.00% | n/a | 41.56% |
| Varex Imaging Corporation | VREX | Diagnostics & Research | 10.56 | 431.49M | 0.57% | 16.69 | 80.92% |
| Myriad Genetics Inc | MYGN | Diagnostics & Research | 4.67 | 424.13M | -1.68% | n/a | 0.00% |
| National Research Corporation | NRC | Diagnostics & Research | 17.33 | 413.69M | 0.99% | 16.76 | 105.03% |
| Pacific Biosciences of California Inc | PACB | Diagnostics & Research | 1.42 | 386.99M | 5.97% | n/a | 187.73% |
| Palatin Technologies Inc | PTN | Diagnostics & Research | 18.03 | 352.45M | 1.75% | n/a | -382.57% |
| Delcath Systems Inc | DCTH | Diagnostics & Research | 9.7 | 271.61M | 0.73% | n/a | 133.18% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| HUYA Inc | HUYA | Media - Diversified | 3.23 | 731.18M | -5.28% | n/a | 0.00% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5 | 726.61M | 1.63% | 11.62 | 116.21% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 16.15 | 673.18M | -3.70% | 42.05 | 64.69% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 5.28 | 610.25M | 1.73% | 65.18 | 77.00% |
| The Marcus Corporation | MCS | Media - Diversified | 18.44 | 593.28M | 3.25% | n/a | 83.32% |
| Ennis Inc | EBF | Building Products & Equipment | 21.77 | 566.10M | 0.37% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 24.28 | 485.37M | -0.82% | n/a | 1.50% |
| AMC Entertainment Holdings Inc | AMC | Media - Diversified | 1.26 | 455.31M | 12.50% | n/a | -511.14% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 20.29 | 336.96M | -0.05% | 34.27 | 26.82% |
| AMC Networks Inc | AMCX | Media - Diversified | 7.38 | 325.44M | 2.93% | 6.32 | 236.34% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.74 | 12.67 | Cheaper |
| Ent. to Revenue | - | 44.00 | - |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.37 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 28,219.30 | 59.59 | Riskier |
| Debt to Equity | - | -14.36 | - |
| Debt to Assets | - | 0.34 | - |
| Market Cap | 795.49M | 13.71B | Emerging |